Atlas Trials

Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma

Clinical trial NCT01813136 · COMPLETED

Trial details

NCT number
NCT01813136
Sponsor
Centre Leon Berard
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Thyroid Carcinoma
Start date
2013-03-01
Primary completion
2019-01-01
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.